Approval · Notice of Compliance 2370 · 2001
VARILRIX: Notice of Compliance 2370
Issued August 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2370
- Date
- August 22, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VARILRIX | 02241047 | Marketed |
Medicinal ingredients
- VARICELLA ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN) 1,995 UNIT per 0.5ML